chrX-38054313-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138780.3(SYTL5):c.220A>T(p.Ile74Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000885 in 1,209,361 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I74M) has been classified as Uncertain significance.
Frequency
Consequence
NM_138780.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SYTL5 | NM_138780.3 | c.220A>T | p.Ile74Phe | missense_variant | 3/17 | ENST00000297875.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SYTL5 | ENST00000297875.7 | c.220A>T | p.Ile74Phe | missense_variant | 3/17 | 5 | NM_138780.3 | P4 | |
SYTL5 | ENST00000456733.2 | c.220A>T | p.Ile74Phe | missense_variant | 2/17 | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000422 AC: 47AN: 111287Hom.: 0 Cov.: 22 AF XY: 0.000418 AC XY: 14AN XY: 33453
GnomAD3 exomes AF: 0.000164 AC: 30AN: 183234Hom.: 1 AF XY: 0.000192 AC XY: 13AN XY: 67728
GnomAD4 exome AF: 0.0000537 AC: 59AN: 1098022Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 13AN XY: 363394
GnomAD4 genome AF: 0.000431 AC: 48AN: 111339Hom.: 0 Cov.: 22 AF XY: 0.000418 AC XY: 14AN XY: 33515
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.220A>T (p.I74F) alteration is located in exon 3 (coding exon 2) of the SYTL5 gene. This alteration results from a A to T substitution at nucleotide position 220, causing the isoleucine (I) at amino acid position 74 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
SYTL5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 09, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at